Sensome Advances Smart Guidewire Technology for Stroke Treatment
PARIS, France, May 20, 2026 Sensome continues to expand the clinical and commercial development of its smart guidewire platform...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
PARIS, France, May 20, 2026 Sensome continues to expand the clinical and commercial development of its smart guidewire platform...
Alameda, California | April 13, 2026 Penumbra, Inc. has announced compelling 90-day results from the STORM-PE randomized controlled trial,...
NEW ORLEANS, February 3, 2026 — Kandu, Inc., a healthcare technology company specializing in brain–computer interface (BCI)–enabled stroke recovery...
CHAPEL HILL, N.C., February 3, 2026 — SonoVascular, Inc., a clinical-stage medical device company focused on improving treatment for...
